Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

22. Oct 2019 | 2 min read

Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

 

Podcast: CEO Dr Hilja Ibert at BioTalk

Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.

Listen to the podcast now:

 

 

HiljaandRichRecording_web-ready

 

BioHealth Innovation and Gentian

Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian's products more visible to a larger US customer base.

 

You may also read


What type of antibodies are used in Gentian’s Cystatin C Immunoassay?

May 20, 2020

What type of antibodies are used in Gentian’s Cystatin C Immunoassay?

In this segment we will answer questions our Product Manager for cystatin C and Product Specialist in the US..

Gentian Insight: PETIA

May 06, 2020

Gentian Insight: PETIA

Gentian’s proprietary antibody and nanoparticle-based technology supports development of highly sensitive..

Webinar: Why choose Gentian Cystatin C Immunoassay

Apr 30, 2020

Webinar: Why choose Gentian Cystatin C Immunoassay

Want to know more about Gentian’s cystatin C immunoassay? Watch this webinar with Gentian’s Product Manager..